Sally Beauty: cheap cash flow, flat sales, and a buyback doing the heavy lifting
Hold at $17.18
Watchlist for new money below $15.62. Sally Beauty trades at 6.8x EBITDA and about 7.5x my Base free cash flow, and the shares are 28.5% below the Base value. But sales are flat, the Beauty Systems Group segment is shrinking, and a 35% margin of safety puts the buy price 9.1% under today's.
- Upside to base value
- 39.9%
- Maximum buy price
- $15.62
- Required margin of safety
- 35%
- EV / EBITDA after stock pay (Base)
- 6.8x
- Price / normalized free cash flow (Base)
- 7.5x
- Net debt leverage (company)
- 1.4x
- Business quality
- 61/100
- Confidence
- 19/25, grade B
In the June quarter, Sally Beauty's sales grew 0.2%, its net earnings grew 18.3% and its earnings per share grew 25.0%. The gap between the last two numbers is the share count, which fell 5.2% in a year.
Sally Beauty is a mature retailer and distributor of professional hair color and beauty supplies. It isn't a growth story, and the shares don't price it as one. What it offers is roughly $200 million a year of free cash flow, half of which management spends on buying back stock, on a market value of about $1.7 billion.
At $17.18 on September 25, 2026, the shares trade 28.5% below my triangulated Base value of $24.03, an upside of 39.9%. The Bear value of $16.24 is 5.5% below the price and the Bull value of $32.02 is 86.4% above it. The framework's required margin of safety for this profile is 35%, which puts the maximum buy price at $15.62. The shares would need to fall about 9.1% to get there. Until then this is a hold: cheap on cash flow, but not yet cheap enough for the risks.
Route: SF-11 Retail and Consumer, specialty beauty retail. Economic classification: Standard, borderline Quality growth (6/12). Primary method: normalized EV/EBITDA. Secondary method: price to normalized free cash flow. SF-10 Dividend Income does not apply, because Sally Beauty pays no dividend. Values are present fair-value estimates, not 12-month price targets.
What Sally Beauty is
Sally Beauty runs two businesses. Sally Beauty Supply is a chain of stores and a website selling hair color, hair care, nails and skin care to salon professionals and to consumers, including its own brands such as Ion, Bondbar and Generic Value Products. Beauty Systems Group (BSG) sells professionally branded products such as Paul Mitchell, Wella and Schwarzkopf to salons, through Cosmo Prof and Armstrong McCall stores and a team of outside sales consultants.
In the third quarter of fiscal 2026 (April to June), Sally Beauty Supply had sales of $538.6 million and BSG $396.9 million. The company ended the quarter with 4,386 stores, 39 fewer than a year earlier, and 558 salon sales consultants against 611.
Two things define the case. Sally Beauty Supply is growing (comparable sales +1.6% in the quarter) and earns a 16.6% operating margin. BSG is shrinking (comparable sales -2.1%) and earns 12.3%. Consolidated comparable sales were flat.
The latest quarter
| Q3 fiscal 2026 (quarter ended June 30, 2026) | Result |
|---|---|
| Net sales | $935.5 million, +0.2%. Sally $538.6 million (+2.2%, comparable +1.6%), BSG $396.9 million (-2.4%, comparable -2.1%). Consolidated comparable sales flat |
| Gross margin | 52.4%, up 90 basis points (adjusted up 40 basis points) |
| Operating earnings | $86.4 million GAAP, 9.2% margin, versus $78.2 million. Adjusted $86.6 million, 9.3% margin |
| Net earnings / per share | $54.1 million (+18.3%), $0.55 per diluted share (+25.0%); adjusted EPS $0.55 (+8%). Diluted shares 97.9 million versus 103.2 million |
| Adjusted EBITDA | $117.4 million, 12.5% margin (+1.8%) |
| E-commerce | $110 million, +11%, 12% of sales |
| Cash flow | Operating cash flow $80.9 million, capital spending $19.3 million, free cash flow $61.6 million (+25.4%) |
| Capital use | $20 million of term loan repaid, 1.9 million shares repurchased for $25 million |
| Cash / debt | $173.1 million / $815.0 million principal ($600.0 million 2032 senior notes and $215.0 million Term Loan B). Company net debt leverage 1.4x |
| Fiscal 2026 guidance (narrowed) | Sales $3.725 to $3.733 billion (was up to $3.750 billion), comparable sales about +0.5%, adjusted operating earnings $329 to $335 million, adjusted EPS $2.04 to $2.08, capital spending about $100 million, free cash flow about $200 million |
Look at what drove the EPS number. Adjusted operating earnings for the first nine months were $239.5 million, against $239.8 million a year earlier. Operating profit was flat, and nine-month adjusted EPS still grew 9% because interest fell and the share count shrank. That is a fair way to make a flat business earn more per share. It is also a reminder that the earnings growth is financial, not operational.
Guidance was narrowed from the top: the upper end of the sales range came down by $17 million and comparable sales are now expected to be about 0.5%, in the middle of a prior range of flat to up 1%. Management pointed to a more promotional market and selective consumers.
Which numbers matter for Sally Beauty
For a mature retailer the primary measure is normalized EBITDA (earnings before interest, taxes, depreciation and amortization), with free cash flow (cash from operations minus capital spending) as the hard control. The company's adjusted EBITDA adds back stock-based compensation (SBC, pay in shares), which was $18.1 million in the first nine months, about $24 million a year. I treat SBC as a real cost and measure EBITDA after it.
Guidance implies fiscal 2026 adjusted operating earnings of about $332 million at the midpoint. Adding roughly $100 million of depreciation and amortization gives about $432 million of EBITDA after SBC (about $456 million on the company's definition, which adds SBC back). My estimates are Bear $420 million, Base $440 million and Bull $455 million. The Base is 1.9% above what guidance implies, so it assumes slightly better than plan, and that matters for a company with no revenue growth.
Free cash flow is where the story is easiest to check. The first nine months produced $163.2 million, which leaves about $37 million for the fourth quarter to reach the guided $200 million. My normalized free cash flow is $190 million in the Bear case, $220 million in the Base and $242.5 million in the Bull (the middle of $235 to $250 million). The Base is 10% above the guided $200 million, so it needs cost savings to stick, and it is shown against the guided figure in the robustness checks.
Shares, debt and buybacks
Diluted shares were 97.9 million in the June quarter, 5.2% fewer than a year earlier. In the first nine months the company bought back 4.9 million shares for $71.4 million, an average of $14.57 a share, and it plans to spend about half of free cash flow, roughly $100 million a year, on repurchases. At the current market value that is about 6% of the company a year. Buybacks add per-share value only below intrinsic value. At $17.18 they are still below my Base of $24.03, but each dollar spent above $15.62 has a thinner cushion than the ones spent at $13.
For per-share values I use 96.47 million diluted shares: 93.62 million shares outstanding plus 2.85 million of dilution from options and share awards, the gap between basic and diluted shares in the latest quarter. This is my estimate. Using the basic count alone would lift every value by about 3%.
| Debt and cash, June 30, 2026 | $ million |
|---|---|
| Long-term debt, including current portion | 807.6 |
| Cash and equivalents | -173.1 |
| Net financial debt | 634.5 |
| Operating lease liabilities (current $161.7 million, long-term $546.1 million) | 707.8 |
| Net debt including leases | 1,342.3 |
The company's 1.4x leverage uses net financial debt and adjusted EBITDA, so it excludes leases. Net debt including leases is $1,342.3 million, and that is what I deduct in the primary valuation. It is a conservative choice, because EBITDA is already stated after rent, and I test the other treatment in the robustness section. The senior notes mature in 2032, and the company has been repaying $20 million of Term Loan B a quarter.
Primary valuation: normalized EV/EBITDA
| Case | EBITDA after SBC | EV/EBITDA | Enterprise value | Equity value | Per share |
|---|---|---|---|---|---|
| Bear | $420M | 7.0x | $2,940M | $1,597.7M | $16.56 |
| Base | $440M | 8.5x | $3,740M | $2,397.7M | $24.85 |
| Bull | $455M | 10.0x | $4,550M | $3,207.7M | $33.25 |
Equity value is enterprise value less $1,342.3 million of net debt including leases, divided by 96.47 million diluted shares. The multiples are a judgment: Sally Beauty has flat sales and a shrinking segment, so I do not give it a premium retail multiple even in the Bull case. The primary Base is $24.85.
Sensitivity: EBITDA and EV/EBITDA
| EBITDA \ Multiple | 7.0x | 8.5x | 10.0x |
|---|---|---|---|
| $420M | $16.6 | $23.1 | $29.6 |
| $440M | $18.0 | $24.9 | $31.7 |
| $455M | $19.1 | $26.2 | $33.2 |
At 7.0x every cell is between $16.6 and $19.1, close to the current price. The whole valuation depends on whether the market pays 7x or 8.5x for a business that doesn't grow.
Secondary valuation: price to normalized free cash flow
| Case | Free cash flow | Per share | P/FCF | Value per share |
|---|---|---|---|---|
| Bear | $190.0M | $1.97 | 8x | $15.76 |
| Base | $220.0M | $2.28 | 10x | $22.80 |
| Bull | $242.5M | $2.51 | 12x | $30.16 |
Free cash flow is independent of the lease treatment, because rent is already paid before it. It is also where this stock looks cheapest: the Base value is 10 times cash flow, and the current price is 7.5 times the same figure. The secondary Base is $22.80.
Current multiples as a cross-check
I could not source a clean history of Sally Beauty's multiples, so I use today's. At $17.18 the shares trade at 8.9x trailing earnings per share of $1.92, and at 8.3x the midpoint of adjusted EPS guidance of $2.06. These are low multiples for a profitable, cash-generative retailer. They are also what you'd expect for one that is growing sales at 0% to 1% and losing stores, so I give the cross-check no weight in the Base.
Valuation triangulation
| Method | Base value | Weight |
|---|---|---|
| EV / normalized EBITDA after SBC | $24.85 | 60% |
| Price / normalized free cash flow | $22.80 | 40% |
| Triangulated Base | $24.03 | 100% |
The weighted result is $24.0336, and I use it without rounding. The primary and secondary methods differ by 8.2%, well under the 20% warning threshold.
What is the market already pricing in?
At $17.18 and 96.47 million diluted shares, market capitalization is about $1,657 million. Adding net debt including leases gives an enterprise value (EV, the price of the whole business including debt) of about $3,000 million, which is 6.8x my Base EBITDA. At the Base multiple of 8.5x, that price implies EBITDA of only about $353 million, 19.8% below my Base.
Cash flow tells the same story more sharply. At 10x, the price implies free cash flow of about $166 million. That is 24.7% below my Base and below the $180 million level that I treat as a thesis breaker. So the market is pricing in a fall in cash flow that has not happened yet, since the first nine months are running 18% ahead of last year. It is betting that flat sales, a shrinking BSG and a promotional market will eat the cost savings.
Bear, base and bull scenarios
| Bear | Base | Bull | |
|---|---|---|---|
| Main assumptions | BSG keeps shrinking, margin gains fade, cash flow slips below the guided level | Stable sales, defensible margins, about $220M of free cash flow, buybacks continue | Margins hold, BSG stabilizes, free cash flow near $240M, the multiple moves toward 10x |
| EBITDA after SBC / free cash flow | $420M / $190M | $440M / $220M | $455M / $242.5M |
| EV/EBITDA / P/FCF | 7.0x / 8x | 8.5x / 10x | 10.0x / 12x |
| Value per share | $16.24 | $24.03 | $32.02 |
| Versus $17.18 | -5.5% | +39.9% | +86.4% |
Bear and Bull are the 60% and 40% blend of the two methods for that case, and the Base is the full triangulation above. I assign no probabilities to the scenarios. A Bear case only 5.5% below the price is not comforting or alarming. It says the price already looks a lot like a bad outcome, and the pain in a worse one would come from a lower multiple as well as lower cash flow.
How the buy price is set
For a Confidence B score, the framework's base margin of safety is 25% to 35%. Mature retail competition, a weak BSG segment and almost no sales growth justify the high end, so the required margin of safety is 35%. Applied to the $24.03 Base, the maximum buy price is $15.62. The shares traded between $11.54 and $17.92 over the past 52 weeks and closed at $15.81 on September 17, so this level is well within recent experience. The current price is 10.0% above it.
Dividend
Sally Beauty does not pay a dividend, so this is not an income thesis. Share repurchases are the only direct cash return, with about half of free cash flow committed to them.
Reasons to own SBH
- Cash generation. Free cash flow for the first nine months was $163.2 million, up from $138.3 million, and the guide is about $200 million.
- Per-share compounding. Diluted shares fell 5.2% in a year, and buybacks at a 7.5x free cash flow multiple are cheap.
- Balance sheet. Company net leverage of 1.4x, no revolver borrowings and a term loan being paid down at $20 million a quarter.
- Margin gains. Gross margin is up 90 basis points and the Fuel for Growth program is on track for $45 million of savings this year.
- A real niche. Sally Beauty Supply is growing its comparable sales, e-commerce grew 11%, and hair color is a consumable category with professional customers.
What could go wrong?
- Flat sales. Nine-month sales grew 1.0% and adjusted operating earnings were unchanged. Earnings per share growth comes from buybacks and lower interest, and both have limits.
- BSG. Sales fell 2.4% in the quarter, comparable sales have been negative for the year to date, and sales consultants are down 8.7%. If this is structural, the consolidated multiple should stay low.
- Cost savings run out. Selling, general and administrative costs rose 4.0% in the first nine months, and part of the gross margin gain came from savings programs that don't repeat.
- Competition. E-commerce, mass-market retailers and other specialty chains all compete for the same shopper, and management describes the market as more promotional.
- Capital allocation. Repurchases create value only below intrinsic value, and only if they don't rebuild leverage. Lease obligations of $708 million sit on top of the debt.
- Management change. The company appointed a new chief financial officer in April 2026.
Management execution
Management has cut debt, held leverage at 1.4x, delivered gross margin gains, kept free cash flow guidance at about $200 million and narrowed the sales range rather than aggressively raising it. It also has flat sales, a shrinking store base and BSG comparable sales that went from +0.5% to -2.1% in a year. Assessment: 14/20, good. The next test is whether margin gains hold while BSG is weak.
Stock Analyza scorecard
| Economic classification | Score |
|---|---|
| Economic return | 1/2 |
| Revenue growth (CAGR) | 0/2 |
| Free cash flow per share growth | 1/2 |
| Balance sheet | 1/1 |
| Unit economics | 1/1 |
| Repeat economics | 1/2 |
| Reinvestment runway | 1/2 |
| Total: Standard, borderline Quality growth | 6/12 |
The raw 6/12 would read as Quality growth, but low organic growth and a limited reinvestment runway make a growth-premium approach inappropriate, so the standard engine applies. Business quality is 61/100: moat and pricing power 12/20, return versus cost of capital 12/20, balance sheet 11/15, earnings and cash flow quality 11/15, growth and runway 6/15, management and allocation 6/10, governance and dilution 3/5. The niche in professional hair color, the specialty assortment and the cash generation are positives. Weak structural growth is the largest constraint.
Confidence score
| Confidence | Score |
|---|---|
| Data quality / source provenance | 4/5 |
| Predictability | 4/5 |
| Valuation robustness | 4/5 |
| Accounting transparency | 4/5 |
| Scenario dispersion | 3/5 |
| Total | 19/25, grade B |
Filings are current and detailed, and the business is stable. Confidence is limited by the fact that fiscal 2026 has not finished, that normalized EBITDA and free cash flow sit above guidance, and by the wide range of multiples the market could apply to a no-growth retailer.
What I would watch from here
Green
- Annual free cash flow of $200 million or more
- Net debt leverage at 1.5x or below
- Consolidated comparable sales at or above 0%
- BSG comparable sales at or above 0%
- Gross margin stable or higher
- Share count falling, with buybacks below fair value
- Inventory growing in line with sales
Yellow
- Free cash flow of $180 to $200 million
- Leverage of 1.5x to 2.0x
- Consolidated comparable sales of -2% to 0%
- BSG comparable sales of -3% to 0%
- Gross margin down 50 to 100 basis points
- Share count flat, buybacks near fair value
- Modest excess inventory
Red
- Free cash flow below $180 million
- Leverage above 2.0x
- Consolidated comparable sales below -2%, sustained
- BSG comparable sales below -3%, sustained
- Gross margin down more than 100 basis points
- Dilution above 2%, or buybacks funded by debt
- A persistent inventory build against sales
Review with the fiscal fourth-quarter and full-year results, which the company usually reports in November. Today BSG comparable sales are -2.1%, gross margin is 52.4%, inventory is $996 million (down 1%) and net leverage is 1.4x.
The three most important thesis breakers
- Free cash flow falling below about $180 million.
- Net debt leverage rising above 2.0x.
- Structural deterioration in BSG, meaning persistent negative comparable sales together with weaker cash flow.
Adversarial review
The first draft's core arithmetic reconciled: EV/EBITDA, price to free cash flow and the upside followed from its own inputs. But checking it against Sally Beauty's third-quarter release and filings found problems that changed the numbers.
| Issue in the first draft | Correction |
|---|---|
| Per-share values used 93.62 million basic shares, while the company reports 97.9 million diluted | 96.47 million diluted-equivalent shares (basic plus the latest quarter's 2.85 million of dilution) |
| Bear value of $18.7 sat 8.8% above the price and matched neither method (the primary Bear was $17.1, and the cash flow leg used Base cash flow at 8x) | Bear is the 60/40 blend of the two methods: $16.24, 5.5% below the price |
| Bull value of $31.0 was set by hand | 60/40 blend of the two methods: $32.02 |
| Base weighted at $24.8 was rounded up to $25.0 | Unrounded weighted result: $24.03 after the other corrections |
| A "historical range" of $22 to $26 was shown as a data point, and the "4.25% year-on-year" share reduction was shown without a filing figure | Removed the range, replaced with current multiples. Share count is taken from the reported diluted counts (-5.2%) |
| Normalized EBITDA and free cash flow were not tied to reported figures, and the SBC treatment was not stated | Tied to guidance (about $432 million EBITDA after SBC, $200 million free cash flow) and to the nine-month results. Base sits 1.9% and 10% above them, stated openly |
| Net debt of $1.34 billion was described without saying that $708 million of it is operating leases | Composition shown. Lease-exclusive treatment tested in the robustness checks |
| Maximum buy $16.25 and upside 45.5% came from the rounded $25.0 Base | Maximum buy $15.62, upside 39.9% |
Net effect: the Base value moved from $25.0 to $24.03, the Bear from $18.7 to $16.24, upside from 45.5% to 39.9%, and the maximum buy price from about $16.25 to $15.62. The Hold and watchlist conclusion survives, and the case is a little thinner than the first draft suggested.
The strongest bear counter-thesis: Sally Beauty may be a classic value trap. Sales have been stagnant for years, BSG is contracting, competition is intense, and margin gains came mostly from cost programs that run out. If free cash flow falls back as the savings mature, a low multiple is fully justified. The strongest bull counter-thesis: the market prices free cash flow at about $166 million while the company has produced $163 million in nine months and guides to $200 million, so any stabilization is worth a re-rating toward 10x. The counter-thesis is credible, which is why the positive case relies on about $200 million of cash flow and moderate leverage, not on growth.
| Robustness check | Result |
|---|---|
| EV / EBITDA after SBC ($440M) at $17.18 | 6.8x |
| Price / Base free cash flow per share ($2.28) | 7.5x |
| Free cash flow at the guided $200M, 10x | $20.73 |
| Triangulated Base if free cash flow is $200M | $23.20 (buy price $15.08) |
| Free cash flow at the $180M breaker, 8x | $14.93 |
| Primary Base if SBC is not deducted (EBITDA $464M) | $26.97 |
| Triangulated Base in that case | $25.30 (buy price $16.45) |
| Primary Base on basic shares (93.62M) | $25.61 |
| Lease-exclusive net debt ($634.5M) at 7.0x | $25.35 |
| Lease-exclusive net debt ($634.5M) at 6.0x | $20.79 |
| Bear | $16.24 |
The lease rows matter. My multiples are judged on a basis that includes leases in debt, which is also how the market multiple of 6.8x is measured. If leases were left out of debt, the same Base EBITDA would need a multiple of about 7x to give the same answer, and 6x would give $20.79. Either way the conclusion holds: the Base sits well above the price, and the buy price sits below it.
Audit flags: normalized EBITDA and free cash flow are my estimates, the Base sits above guidance for both, and the diluted share count is an approximation. Fiscal 2026 results are not final. The September 25 close of $17.18 is confirmed by two market data sources. No unresolved arithmetic error remains. The publication gate status is PASS WITH WARNING.
Final verdict: hold at $17.18, watchlist for new money below $15.62
Sally Beauty is a mature, cash-generative retailer priced at 6.8x EBITDA and 7.5x my Base free cash flow. That is cheap, and it is cheap for reasons: flat sales, a shrinking BSG segment, a store base that is getting smaller, and earnings per share that grow mainly through buybacks. The price does not offer the full 35% margin of safety those risks call for, and it takes a fall of about 9% to reach it.
Sally Beauty's sales barely move, and the price already agrees with that. What the price does not agree with is nine months of free cash flow running 18% ahead of last year. One of the two has to give, and the fourth-quarter cash flow will be the first evidence.
Verdict: WATCHLIST at $17.18. Triangulated Base value $24.03, upside 39.9%, Confidence B (19/25). Required margin of safety 35%, maximum buy price $15.62.
The case improves if free cash flow reaches $200 million or more while BSG comparable sales return to zero, or if the price falls into the buy zone with the fundamentals intact.
Sources
Primary sources include Sally Beauty's third-quarter fiscal 2026 earnings release and financial tables (August 3, 2026), its Form 10-Q for the quarter ended June 30, 2026, its second-quarter release and 10-Q, and the third-quarter earnings call. The market price comes from StockAnalysis.com and Market Chameleon.
The reference market price is $17.18, the September 25, 2026 close. Balance sheet figures are as of June 30, 2026. Fiscal 2026 is not yet complete. Normalized EBITDA, normalized free cash flow, the diluted share count and scenario values are analytical estimates, not company guidance.
Disclaimer. This analysis is provided solely for research and educational purposes. It is not personalized investment, financial, legal or tax advice. Sally Beauty operates in a competitive, low-growth retail market, carries debt and lease obligations, and reports adjusted figures that exclude real costs. Investors can lose part or all of their invested capital.
Framework: SF-11, specialty beauty retail. Economic class: Standard, borderline Quality growth. Engine: STANDARD. Confidence: B/19. Data status: PASS WITH WARNING. Adversarial gate: PASS WITH WARNING. Version: Master v3.1.